Search Results - "Wadwa, R. P."

ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents by Donaghue, Kim C., Marcovecchio, M. Loredana, Wadwa, R. P., Chew, Emily Y., Wong, Tien Y., Calliari, Luis Eduardo, Zabeen, Bedowra, Salem, Mona A., Craig, Maria E.

Get full text

The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes by KRETOWSKI, A, HOKANSON, J. E, LI, J, CHENG, S, ERLICH, H. A, REWERS, M, MCFANN, K, KINNEY, G. L, SNELL-BERGEON, J. K, MAAHS, D. M, WADWA, R. P, ECKEL, R. H, OGDEN, L. G, GARG, S. K

“…Individuals with type 1 diabetes have an increased incidence of coronary artery disease (CAD) and a higher risk of cardiovascular death compared with…”
Get full text

Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study by DiMeglio, L. A., Kanapka, L. G., DeSalvo, D. J., Anderson, B. J., Harrington, K. R., Hilliard, M. E., Laffel, L. M., Tamborlane, W. V., Van Name, M. A., Wadwa, R. P., Willi, S. M., Woerner, S., Wong, J. C., Miller, K. M.

“…Aim To assess the associations between demographic and clinical characteristics and sensor glucose metrics in young children with type 1 diabetes, using…”
Get full text

Pneumococcal Vaccine: An Update by Wadwa, R. Paul

“…The Streptococcus (S.) pneumoniae bacterium is a significant cause of ear infections, meningitis, and pneumonia in both children and adult, but current vaccine…”
Get full text

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes by Brown, Sue A, Kovatchev, Boris P, Raghinaru, Dan, Lum, John W, Buckingham, Bruce A, Kudva, Yogish C, Laffel, Lori M, Levy, Carol J, Pinsker, Jordan E, Wadwa, R. Paul, Dassau, Eyal, Doyle, Francis J, Anderson, Stacey M, Church, Mei Mei, Dadlani, Vikash, Ekhlaspour, Laya, Forlenza, Gregory P, Isganaitis, Elvira, Lam, David W, Kollman, Craig, Beck, Roy W

“…Closed-loop systems that automate insulin delivery may improve glycemic outcomes in patients with type 1 diabetes. In this 6-month randomized, multicenter…”
Get full text

Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial by Klein, David J, Battelino, Tadej, Chatterjee, D J, Jacobsen, Lisbeth V, Hale, Paula M, Arslanian, Silva

“…The prevalence of type 2 diabetes (T2D) in youth is increasing. Treatment options beyond metformin and insulin are needed. The safety, tolerability,…”
Get more information

Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial by Ware, Julia, Boughton, Charlotte K, Allen, Janet M, Wilinska, Malgorzata E, Tauschmann, Martin, Denvir, Louise, Thankamony, Ajay, Campbell, Fiona M, Wadwa, R Paul, Buckingham, Bruce A, Davis, Nikki, Besser, Rachel E J, Weinzimer, Stuart A, Hood, Korey K, Kanapka, Lauren, Kollman, Craig, Beck, Roy W, Hovorka, Roman, Hovorka, R, Thankamony, A, Allen, J M, Boughton, C K, Dunger, D B, Ware, J, Musolino, G, Wilinska, M E, Hayes, J F, Slegtenhorst, S, Ruan, Y, Haydock, M, Mangat, J, Denvir, L, Law, J, Sachdev, P, Saxton, M, Stafford, S, Keeton, R, Cresswell, R, Fazackerley, H, Looby, L, Saddington, C, Smith, V, Verhoeven, V, Bratt, S, Khan, N, Moyes, L, Sandhu, K, West, C, Wadwa, R P, Alonso, G, Forlenza, G, Escobar, E, Jost, E, Messer, L, Campbell, F M, Yong, J, Metcalfe, E, Allen, M, Waheed, S, Exall, J, Tulip, J, Buckingham, B A, Norlander, L, Jacobson, T, Twon, M, Leverenz, B, Keller, J, Dewar, H, Mauras, N, Benson, M, Bird, K, Englert, K, Permuy, J, Ponthieux, K, DiMeglio, L A, Ismail, H, Besser, R EJ, London, R, Ryan, F, Bowen-Morris, J, Law, R, Deakin, M, Phelan, K, Cengiz, E, Van Name, M, Steffen, A, Zgorski, M, Davis, J, Hellman, A, Kanapka, L, McCarthy, C, Chalasani, S, Lanning, M, Eggerman, T, Janicek, R, Gabrielson, D, Castle, J, Green, J, Legault, L, Wysham, C

“…Closed-loop insulin delivery systems have the potential to address suboptimal glucose control in children and adolescents with type 1 diabetes. We compared…”
Get full text

Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women

Get full text

The effect of insurance status and parental education on glycemic control and cardiovascular disease risk profile in youth with Type 1 Diabetes by Majidi, Shideh, Wadwa, R Paul, Bishop, Franziska K, Klingensmith, Georgeanna J, Rewers, Marian, McFann, Kim, Maahs, David M

“…Background Adult studies have shown a correlation between low socioeconomic status and Type 1 Diabetes complications, but studies have not been done in…”
Get full text

Glucose Control Predicts 2-Year Change in Lipid Profile in Youth with Type 1 Diabetes by Maahs, David M., MD, PhD, Dabelea, Dana, MD, PhD, D'Agostino, Ralph B., PhD, Andrews, Jeannette S., MS, Shah, Amy S., MD, Crimmins, Nancy, MD, Mayer-Davis, Elizabeth J., PhD, Marcovina, Santica, PhD, Imperatore, Giuseppina, MD, PhD, Wadwa, R. Paul, MD, Daniels, Steven R., MD, PhD, Reynolds, Kristi, MPH, PhD, Hamman, Richard F., MD, DrPH, Dolan, Lawrence M., MD

“…Objective To test the hypothesis that a change in glycated hemoglobin (A1c) over a follow-up interval of approximately 2 years would be associated with…”
Get full text

β-Cell Function, Insulin Sensitivity, and Glucose Tolerance in Obese Diabetic and Nondiabetic Adolescents and Young Adults by Elder, Deborah A., Prigeon, Ronald L., Wadwa, R. Paul, Dolan, Lawrence M., D’Alessio, David A.

“…Context: Type 2 diabetes mellitus (T2DM) is estimated to account for 10–45% of incident pediatric diabetes cases. Objective: Our objective was to characterize…”
Get full text

Awareness and Treatment of Dyslipidemia in Young Adults With Type 1 Diabetes by Wadwa, R. Paul, Kinney, Gregory L, Maahs, David M, Snell-Bergeon, Janet, Hokanson, John E, Garg, Satish K, Eckel, Robert H, Rewers, Marian

“…OBJECTIVE:--Dyslipidemia is a preventable major risk factor for coronary heart disease (CHD). Despite an increased risk of CHD in type 1 diabetes, little is…”
Get full text

Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes by Wadwa, R. Paul, Kinney, Gregory L., Ogden, Lorraine, Snell-Bergeon, Janet K., Maahs, David M., Cornell, Elaine, Tracy, Russell P., Rewers, Marian

“…Soluble interleukin-2 receptor (sIL2r), a marker of T cell activation, is elevated in inflammatory processes, such as rheumatoid arthritis, hepatitis and…”
Get full text

Total Cholesterol and High-Density Lipoprotein Levels in Pediatric Subjects with Type 1 Diabetes Mellitus by Maahs, David M., Maniatis, Aristides K., Nadeau, Kristen, Wadwa, R. Paul, McFann, Kim, Klingensmith, Georgeanna J.

“…This study reports serum lipid levels in 682 children with type 1 diabetes mellitus. We found that 3.5% of the subjects had a high-density lipoprotein (HDL)…”
Get full text